Evidence map›Paper›PMID 40097665›Full record

ReviewBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz2025

[Vaccination reminders in Germany: inventory and ideas for tomorrow using the example of HPV vaccination : Report on the results of the InveSt HPV project].

Anja Takla, Elisa Wulkotte, Yvonne Bichel, Johannes Lachmann, Angelika Trübswetter, Julia Wilhelm, Annabel Zettel, Nora Schmid-Küpke

Abstract readEnglish AbstractReview
In one paragraph

Review in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anja TaklaFachgebiet Impfprävention, STIKO, Abteilung für Infektionsepidemiologie, Robert Koch-Institut, Berlin, Deutschland. TaklaA@rki.de.
Elisa WulkotteFachgebiet Impfprävention, STIKO, Abteilung für Infektionsepidemiologie, Robert Koch-Institut, Berlin, Deutschland.
Yvonne BichelFachgebiet Impfprävention, STIKO, Abteilung für Infektionsepidemiologie, Robert Koch-Institut, Berlin, Deutschland.
Johannes LachmannFachgebiet Impfprävention, STIKO, Abteilung für Infektionsepidemiologie, Robert Koch-Institut, Berlin, Deutschland.
Angelika TrübswetterYOUSE GmbH, Berlin, Deutschland.
Julia WilhelmFachgebiet Impfprävention, STIKO, Abteilung für Infektionsepidemiologie, Robert Koch-Institut, Berlin, Deutschland.
Annabel ZettelYOUSE GmbH, Berlin, Deutschland.
Nora Schmid-KüpkeFachgebiet Impfprävention, STIKO, Abteilung für Infektionsepidemiologie, Robert Koch-Institut, Berlin, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Germany, vaccinations take place almost exclusively in physicians' private practices. This means that every contact with a practice or physician is an important opportunity to receive a recommended vaccination. The effectiveness of invitation and reminder systems for the implementation of recommended vaccinations has already been proven by studies, but in contrast to many other countries, such systems are not used across the board in Germany. The "Intervention Study to Increase HPV Vaccination Coverage in Germany" (InveSt HPV) therefore addresses, among other things, the question of what barriers exist to the use and dissemination of invitation and vaccination reminder systems. To this end, two nationwide quantitative surveys of (i) 345 pediatricians in private practices and (ii) 1805 parents with children aged 9 to 14 as well as a survey of 46 statutory health insurances with around 51 million insured persons were conducted. The survey results and other evidence compiled by the project team formed the basis for a workshop with vaccination-relevant stakeholders from the healthcare sector. The aim of the workshop was to work together on concepts for a future invitation and vaccination reminder system in Germany using the specific example of the HPV (Human Papillomavirus) vaccination. This report presents the core results of the surveys conducted and selected additional evidence compiled by the project team for the workshop. Finally, the workshop and the key elements developed by the participants for an HPV-related invitation and vaccination reminder system 2.0 are described.

Indexed as

Mass VaccinationPapillomavirus InfectionsPapillomavirus VaccinesReminder SystemsVaccinationVaccination CoverageAdolescentAdultChildFemaleForecastingGermanyHumansMalePapillomavirus VaccinesAcceptanceEquityEvidenceHPV vaccinationRecall

Identifiers

PMID40097665
PMCPMC11950045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.